In an exclusive interview with VOA, the director of Oxford University’s Jenner Institute says their new malaria vaccine, tested in Burkina Faso, has shown a preliminary efficacy rate of 77%, which could help prevent over 400,000 deaths a year, most of them in sub-Saharan Africa
While laboratory evidence demonstrates hope for the drug, the results are inconclusive, prompting the creation of the international, double-blind study.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use. <br> To find out more, including how to control cookies, see here: <a href="https://automattic.com/cookies"> Cookie Policy </a> more information
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy